title: Progression to hepatitis and fibrosis secondary to lomitapide use--reply.
authors.affiliation: Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts2Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts3Harvard Medical School, Boston, Massachusetts.
authors.forename: Frank M
authors.initials: FM
authors.lastname: Sacks
authors.affiliation: Harvard Vanguard Medical Associates, Boston, Massachusetts.
authors.forename: Maxine
authors.initials: M
authors.lastname: Stanesa
authors.affiliation: Robarts Research Institute, London, Ontario, Canada.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Hegele
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015228:Hypertriglyceridemia / Q000150:complications* / Q000188:drug therapy*; D050500:Pancreatitis, Chronic / Q000188:drug therapy*; D011247:Pregnancy
chemical_list: D000924:Anticholesteremic Agents; D001562:Benzimidazoles